Correlation Between NYSE Composite and Vascular Biogenics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Vascular Biogenics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Vascular Biogenics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Vascular Biogenics, you can compare the effects of market volatilities on NYSE Composite and Vascular Biogenics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Vascular Biogenics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Vascular Biogenics.
Diversification Opportunities for NYSE Composite and Vascular Biogenics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NYSE and Vascular is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Vascular Biogenics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vascular Biogenics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Vascular Biogenics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vascular Biogenics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Vascular Biogenics go up and down completely randomly.
Pair Corralation between NYSE Composite and Vascular Biogenics
If you would invest 28.00 in Vascular Biogenics on September 13, 2024 and sell it today you would earn a total of 0.00 from holding Vascular Biogenics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.55% |
| Values | Daily Returns |
NYSE Composite vs. Vascular Biogenics
Performance |
| Timeline |
NYSE Composite and Vascular Biogenics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Vascular Biogenics
Pair trading matchups for Vascular Biogenics
Pair Trading with NYSE Composite and Vascular Biogenics
The main advantage of trading using opposite NYSE Composite and Vascular Biogenics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Vascular Biogenics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vascular Biogenics will offset losses from the drop in Vascular Biogenics' long position.| NYSE Composite vs. Air Products and | NYSE Composite vs. Allient | NYSE Composite vs. Ecovyst | NYSE Composite vs. CTS Corporation |
| Vascular Biogenics vs. Revelation Biosciences | Vascular Biogenics vs. Zura Bio Limited | Vascular Biogenics vs. Phio Pharmaceuticals Corp | Vascular Biogenics vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |